Trial Outcomes & Findings for Gynecologic Brachytherapy-Specific Educational Video (NCT NCT04363957)

NCT ID: NCT04363957

Last Updated: 2025-10-14

Results Overview

Primary Analysis based on Intention-to-Treat population, defined as all individuals who were randomized to arm A or arm B. A Likert-scale study specific questionnaire (no unabbreviated scale title, Likert-scale is a general untitled tool) is used to calculate satisfaction score. Using the brachytherapy specific questionnaire, the study team will examine three patient reported time points for impact: baseline, after the consent process, and prior to the last brachytherapy procedure. For primary endpoint, a two-sample t-test will be used to compare differences of satisfaction scores at two time points (baseline and following consent process) between groups. The reporting scale is the following: Strongly disagree (1); Disagree (2); Uncertain (3); Agree (4); Strongly agree (5) Minimum: 1; Maximum: 5. Questionnaire had 12 questions. Minimum possible score is 12; Maximum possible score is 60. Higher score means higher satisfaction.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

80 participants

Primary outcome timeframe

Baseline

Results posted on

2025-10-14

Participant Flow

Participant milestones

Participant milestones
Measure
Standard Consent
Patients only receive the standard brachytherapy consent process Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Standard Consent and Video Intervention
Patients receive the standard brachytherapy consent process and the addition of an informational video about brachytherapy Brachytherapy video: Patients will watch a video that contains information about brachytherapy Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Overall Study
STARTED
40
40
Overall Study
COMPLETED
29
28
Overall Study
NOT COMPLETED
11
12

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Gynecologic Brachytherapy-Specific Educational Video

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Standard Consent
n=29 Participants
Patients only receive the standard brachytherapy consent process Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Standard Consent and Video Intervention
n=28 Participants
Patients receive the standard brachytherapy consent process and the addition of an informational video about brachytherapy Brachytherapy video: Patients will watch a video that contains information about brachytherapy Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Total
n=57 Participants
Total of all reporting groups
Age, Continuous
58 Years
n=5 Participants
60 Years
n=7 Participants
59 Years
n=5 Participants
Sex: Female, Male
Female
29 Participants
n=5 Participants
28 Participants
n=7 Participants
57 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
5 Participants
n=5 Participants
7 Participants
n=7 Participants
12 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
22 Participants
n=5 Participants
20 Participants
n=7 Participants
42 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Primary Cancer
Cervix
15 Participants
n=5 Participants
16 Participants
n=7 Participants
31 Participants
n=5 Participants
Primary Cancer
Uterine
13 Participants
n=5 Participants
10 Participants
n=7 Participants
23 Participants
n=5 Participants
Primary Cancer
Vagina
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline

Primary Analysis based on Intention-to-Treat population, defined as all individuals who were randomized to arm A or arm B. A Likert-scale study specific questionnaire (no unabbreviated scale title, Likert-scale is a general untitled tool) is used to calculate satisfaction score. Using the brachytherapy specific questionnaire, the study team will examine three patient reported time points for impact: baseline, after the consent process, and prior to the last brachytherapy procedure. For primary endpoint, a two-sample t-test will be used to compare differences of satisfaction scores at two time points (baseline and following consent process) between groups. The reporting scale is the following: Strongly disagree (1); Disagree (2); Uncertain (3); Agree (4); Strongly agree (5) Minimum: 1; Maximum: 5. Questionnaire had 12 questions. Minimum possible score is 12; Maximum possible score is 60. Higher score means higher satisfaction.

Outcome measures

Outcome measures
Measure
Standard Consent
n=29 Participants
Patients only receive the standard brachytherapy consent process Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Standard Consent and Video Intervention
n=28 Participants
Patients receive the standard brachytherapy consent process and the addition of an informational video about brachytherapy Brachytherapy video: Patients will watch a video that contains information about brachytherapy Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Patient Reported Satisfaction
54 satisfaction score at baseline
Interval 45.0 to 54.0
55 satisfaction score at baseline
Interval 49.0 to 55.0

SECONDARY outcome

Timeframe: Baseline

Satisfactory scores at three time points will be analyzed using a mixed effect model for repeated measures (MMRM) to assess satisfactory scores trajectories between two arms. The MMRM model will include terms for time, consent arm, baseline score, arm-by-time interaction, baseline score by time interaction, plus covariates that include age, stage. Time will be treated as categorical. If values of last two time points are similar, analysis of covariance model (ANCOVA) will be used to model the change in satisfactory scores. The mean of the last two time points will be calculated. That is, the after consent score (mean values) will be regressed upon baseline score and consent arms. Patient treatment-related anxiety between groups, defined as National Comprehensive Cancer Network (NCCN) distress score, are also collected at three time points and will be analyzed using the same strategy. The NCCN distress scale is from 0 (min) -10 (max) with 10 being a value that is more distress- worse.

Outcome measures

Outcome measures
Measure
Standard Consent
n=29 Participants
Patients only receive the standard brachytherapy consent process Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Standard Consent and Video Intervention
n=28 Participants
Patients receive the standard brachytherapy consent process and the addition of an informational video about brachytherapy Brachytherapy video: Patients will watch a video that contains information about brachytherapy Standard Brachytherapy Consent Process: Patients will have the standard clinical brachytherapy consent and education including discussion with their physician.
Treatment Related Anxiety
4 anxiety score at baseline
Interval 2.0 to 7.0
4 anxiety score at baseline
Interval 1.0 to 6.0

Adverse Events

Standard Consent

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Standard Consent and Video Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Dr. Jyoti Mayadev

University of California, San Diego

Phone: (858) 822-5354

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place